SMAD7 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, we found that the TGF-β/BMP pathway was coordinately downregulated in the CML LSC compared to normal HSC, and pathway antagonists, such as SMAD7 were highly activated.